Juili Lillian Lin-Goerke

Title: Innovations of Juili Lillian Lin-Goerke in Colorectal Cancer Diagnosis

Introduction

Juili Lillian Lin-Goerke is an accomplished inventor based in Spring City, PA (US). He has made significant contributions to the field of genetics, particularly in the diagnosis of colorectal cancer. His work focuses on the mutations in human MLH1 and MSH2 genes, which are crucial for understanding hereditary non-polyposis colorectal cancer (HNPCC).

Latest Patents

Juili holds a patent for "Mutations in human MLH1 and human MSH2 genes useful in diagnosing colorectal cancer." This patent includes variant human MLH1 and MSH2 genes that are instrumental in diagnosing HNPCC and determining a patient's susceptibility to developing this condition. The patent also outlines methods and compositions for identifying new variant MLH1 and MSH2 genes, as well as experimental models for HNPCC that incorporate these variant genes.

Career Highlights

Juili is currently employed at Diadexus, Inc., where he continues to advance research in genetic diagnostics. His innovative work has the potential to significantly impact the early detection and treatment of colorectal cancer, improving patient outcomes.

Collaborations

Juili collaborates with notable colleagues, including David Robbins and Jessica C Ling, who contribute to the research and development efforts at Diadexus, Inc. Their teamwork fosters an environment of innovation and discovery in the field of genetic research.

Conclusion

Juili Lillian Lin-Goerke's contributions to the understanding and diagnosis of colorectal cancer through genetic research are invaluable. His patent and ongoing work at Diadexus, Inc. highlight the importance of innovation in medical science.